CEO Kevin Richardson of SANUWAVE Health, Inc. (OTCQB: SNWV), rejoins Stock Day to talk about recent FDA approval of the dermaPACE device, using innovative shock wave therapy for wound care.

OTCQB: SNWV # FDA Clearance # European conference # PACE Science # wound healing # Diabetic Foot Ulcers # Orthopedics # acoustic shockwave therapy # Arteriogenesis # Diabetic Foot Ulcers # International Distributors # Penny Stocks # wound healing # Symposium of Advanced Wound Care # Europe # Brazlian market